EP1861169
Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.3.2006EP published:
11.5.2016EP application number:
06730328.9
EPO information:
European Patent Register
Max expiry date:
21.3.2026
Title:
Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer
Timeline
Today
22.3.2006EP application
11.5.2016EP Publication
Owner
Name:
Sucampo AGAddress:
Baarerstrasse 22, 6300, Zug, CH
Name:
NORTH CAROLINA STATE UNIVERSITYAddress:
4700 Hillsborough Street, 27606, Raleigh, NC, US
Inventor
Name:
UENO, RyujiAddress:
Maryland, US
Name:
KUNO, SachikoAddress:
Maryland, US
Name:
BLIKSLAGER, Anthony, T.Address:
Apex, NC, US
Name:
MOESER, Adam, J.Address:
Raleigh, NC, US
Priority
Number:
663200 PDate:
21.3.2005Country:
US
Number:
679920 PDate:
11.5.2005Country:
US
Number:
721976 PDate:
30.9.2005Country:
US
Classification
Categories:
A61P 1/04, A61P 35/00, A61K 31/557, C07C 405/00